NAGA Monoclonal antibody
NAGA Monoclonal Antibody for WB, ELISA
Host / Isotype
Mouse / IgG2b
Reactivity
Human
Applications
WB, ELISA
Conjugate
Unconjugated
CloneNo.
2A5F3
Cat no : 67684-1-Ig
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | U2OS cells, LNCaP cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:2000-1:10000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
67684-1-Ig targets NAGA in WB, ELISA applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG2b |
Class | Monoclonal |
Type | Antibody |
Immunogen | NAGA fusion protein Ag7225 |
Full Name | N-acetylgalactosaminidase, alpha- |
Calculated Molecular Weight | 47 kDa |
Observed Molecular Weight | 50 kDa |
GenBank Accession Number | BC000095 |
Gene Symbol | NAGA |
Gene ID (NCBI) | 4668 |
RRID | AB_2882877 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
NAGA belongs to the glycosyl hydrolase 27 family. It removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. It is required for the breakdown of glycolipids. Biosynthetic studies performed with cultured fibroblasts indicated that the human enzyme was synthesized as a 65 kDa glycosylated precursor which was processed to a mature 48-kDa lysosomal form; both the precursor and mature forms had high mannose type oligosaccharide chains, but only the precursor's mannose residues were phosphorylated. 90-117 kDa is a homodimer of NAGA.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for NAGA antibody 67684-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |